HEART FAILURE ATTRIBUTABLE TO SEVERE TRICUSPID REGURGITATION

Clinical trials for HEART FAILURE ATTRIBUTABLE TO SEVERE TRICUSPID REGURGITATION explained in plain language.

Never miss a new study

Get alerted when new HEART FAILURE ATTRIBUTABLE TO SEVERE TRICUSPID REGURGITATION trials appear

Sign up with your email to follow new studies for HEART FAILURE ATTRIBUTABLE TO SEVERE TRICUSPID REGURGITATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New heart valve fix aims to cut deaths and hospital stays

Disease control Ongoing

This trial is testing if a minimally invasive procedure to repair a severely leaking heart valve (tricuspid valve) is better than medication alone for people with heart failure. About 360 patients who are too high-risk for open-heart surgery will be randomly assigned to receive e…

Matched conditions: HEART FAILURE ATTRIBUTABLE TO SEVERE TRICUSPID REGURGITATION

Phase: NA • Sponsor: LMU Klinikum • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

HEART FAILURE ATTRIBUTABLE TO SEVERE TRICUSPID REGURGITATION

Get alerted when new HEART FAILURE ATTRIBUTABLE TO SEVERE TRICUSPID REGURGITATION trials appear

New heart valve fix aims to cut deaths and hospital stays